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E-mail address: lill.martensson@rheuma.gu.se (I.-LB lymphocytes are essential antibody-producing cells of the immune system. During the develop-
ment of progenitor B cells to mature B cells that express a membrane-bound antibody, the B cell
receptor (BCR), the cells undergo selection at several checkpoints, which ensures that a diverse anti-
body repertoire is generated and that the BCRs recognise foreign-, but not self-, antigens. In this
review, we consider the pre-BCR checkpoint. Mutations or alterations that affect this checkpoint
underpin the development of pre-B cell leukemias, primary immunodeﬁciency, and possibly, sys-
temic autoimmunity.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. The pre-B cell receptor
Following the discovery of pre-B cells as precursors of B cells,
the pre-B cell receptor (pre-BCR) was identiﬁed as a ‘precursor’
of the B cell receptor (BCR) [1–3]. The observation that the leu-
kemic cells in most children with acute lymphoblastic leukemia
were classiﬁed as pre-B cells [4], suggested the importance of
this developmental stage. Whereas the BCR is assembled from
the immunoglobulin (Ig) heavy (H) and light (L) chains, the
pre-BCR is assembled from Ig H and surrogate L (SL) chains,
the latter composed of the invariant k5 and VpreB polypeptides
and having homology to bona ﬁde Ig L chains [5–8]. Since the
discovery of the pre-BCR, several groups have investigated the
roles of the pre-BCR and SL chain [9]. It is clear that the pre-
BCR is essential for B cells to develop normally, and that muta-
tions or alterations affecting the pre-BCR underpins the develop-
ment of cancer and immunodeﬁciency, and perhaps even
autoimmunity [3,10,11].chemical Societies. Published by E
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. Mårtensson).2. Antibody diversity
Antibodies are mediators of humoral immune responses, which
participate in protection against pathogens. An antibody consists of
an identical pair of H and L chains, each with a variable and a con-
stant region, which are responsible for antigen recognition and
effector functions, respectively (Fig. 1). Within the variable region,
three hypervariable regions (known as ‘complementarity deter-
mining regions’; CDR1-3) determine antigen recognition. This
hypervariability is established at the DNA level through a somatic
process termed V(D)J recombination, whereby variable (V), diver-
sity (D), and joining (J) gene segments are recombined [12]. The
mouse H chain locus, for instance, contains >100 functional V gene
segments, >10 D segments, and four J gene segments [13]. Together
with recombinations of the L chain loci, this diversity theoretically
yields >1012 different antibodies.
The products of the lymphoid-speciﬁc recombination-activating
genes (RAG1 and RAG2) are required for the recombination process
[14,15]. These proteins bind the recombination signal sequences
that ﬂank each gene segment, and this is followed by a double-
strand break in the DNA, which is the initial event in the bringing
together of the gene segments (Fig. 2).
The diversity results from the VH gene segment itself (which en-
codes CDR1 and CDR2), the recombination of the VH, D, and JH gene
segments, as well as the actual process of joining. The asymmetri-
cal cleavage of the gene segments and the removal/addition of
nucleotides between segments at the time of joining result in var-
iability at the junctions, which is termed ‘junctional diversity’.lsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of an antibody. Overall structure of an antibody,
when expressed on the cell surface pf B cells termed the B cell receptor (BCR), and
consisting of Ig H (HC, in green) and Ig L (LC, in blue) chains. Each chain consists of a
constant (C) and a variable (V) region.
I.-L. Mårtensson et al. / FEBS Letters 584 (2010) 2572–2579 2573In addition, the terminal deoxyribonucleotidyl transferase, an en-
zyme that is highly expressed in the adult, adds N nucleotides at
the V–D–JH junctions. As this junction encodes the H chain CDR3
(HC-CDR3), it is the most diverse of the CDRs and the major deter-
minant of antibody speciﬁcity [16].7 12/ 23 9
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Fig. 2. The VDJ rearrangement process. (a) Depicted is a recombination signal sequence
length of the spacer is crucial, as recombination requires one gene segment with a 12-b
rearrangement process is exempliﬁed by that of the Ig H chain locus. The D (diversity) an
(variable) segment to the DJ segment. The complete VDJ gene segment is then transcribed
is encoded by the V–D–J joint.3. B-cell development
In this section, we describe B-cell development in detail, so as to
facilitate later discussions in which stage and Ig recombination sta-
tus become important (Fig. 3). B cells originate from a pool of
hematopoietic stem cells in bone marrow niches, i.e. microenvi-
ronments that are optimal for their maintenance. One of the cell
types in this microenvironment is stromal cells, which secrete fac-
tors, e.g., interleukins and may also provide cell–cell contact.
Early studies, mostly using cell lines, showed that DJH recombi-
nation occurs before VDJH, and that this is followed by VJL recom-
bination, thereby establishing the order of V(D)J recombination
[17,18]. However, to study B-cell development using freshly iso-
lated cells, it was necessary to deﬁne unique combinations of sur-
face markers that could distinguish cells based on recombination
status [19]. The combination of cluster of differentiation (CD) anti-
gens allows the separation of B-cell development into several con-
secutive stages. Although these surface proteins have functions,
the present discussion is limited to their use as markers. In mice,
two nomenclatures are used: (1) the Philadelphia nomenclature,
which applies B220 (CD45), CD43, CD24 (HSA), BP-1, and IgM
expression to deﬁne fraction A–F [20]; and (2) the Basel nomencla-
ture, which refers to the expression of B220, CD117 (c-kit), CD25,
and IgM [21]. Other markers (e.g., CD19) have been added over
the years. As the two systems do not completely overlap, it is
sometimes difﬁcult to extrapolate from one nomenclature to the
other.CµJH (4)H (13)
5’ AAAA 3’
CDR3
(RSS) that consists of a heptamer, a spacer of 12 bp or 23 bp, and a nonamer. The
p spacer and another with a 23-bp spacer, i.e. the 12/23 rule, as illustrated. (b) The
d J (joining) gene segments are recombined ﬁrst, followed by recombination of the V
into mRNA, which is translated into lH chains. The hypervariable region, HC-CDR3,
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Fig. 3. Schematic illustration of B-cell development. In adults, B-cell development takes place in the bone marrow; thereafter the immature B cells migrate to the spleen,
where maturation is completed. The different stages are deﬁned by the recombination status of the Ig H and Ig L chain loci in combination with the expression of cell surface
markers (Basel nomenclature [21]), as indicated. It should be noted that changes in marker levels are not indicated. The formation of the pre-B cell receptor (pre-BCR)
constitutes the ﬁrst major checkpoint of B-cell development, the pre-BCR checkpoint.
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ﬁguration, in contrast to progenitor B cells (B220+CD19CD117+),
which have initiated D to JH recombination of the H chain locus.
At the pre-BI stage (B220+CD19+CD117+), all cells express the SL
chain and most of the cells have completed DJH recombination
on both alleles. In addition, approximately 20% of the pre-BI cells,
termed ‘transitional pre-BI cells’ [22], have successfully com-
pleted VDJH recombination, as evidenced by their expression of
lH chains. Although the H chain locus contains several constant
regions (d, c, a, e), the lH chain is the ﬁrst to be expressed. In
transitional pre-BI cells, the lH chains assemble with the SL chain
to form a pre-BCR [23–25]. This associates with Iga and Igb, the
signalling molecules that transduce signals via this receptor. The
pre-BCR is also expressed at the subsequent large cycling pre-
BII stage (B220+CD19+CD25+). As these cells exit the cell cycle
and become small pre-BII cells, SL chain is no longer detected
and the Ig L chain loci undergo recombination. Synthesis of a L
chain, either j or k, leads to assembly of a BCR. By analogy to
the pre-BCR, the BCR associates with Igab and is expressed on
the cell surface as a membrane-anchored antibody, i.e. IgM. The
cells are now deﬁned as immature B cells. Although the CD93
marker is expressed also at earlier stages of development, it is
used to distinguish immature (CD93+) from mature (CD93) B
cells [26]. Immature B cells leave the bone marrow and migrate
to the spleen where they mature further and co-express IgM
and IgD.
4. Peripheral B-cell subsets and immune responses
Mature B cells, which are also found in other peripheral lym-
phoid organs, such as lymph nodes, can be divided into subsets
based on location. All these B cells have the ability to differentiate
into antibody-secreting plasma cells, although their responses dif-
fer. Follicular B cells, which predominate in the spleen and lymph
nodes, typically respond to protein antigens, triggering immune re-
sponses that involve T-helper cells and the formation of germinalcentres. In germinal centres, B cells proliferate extensively, and
their BCRs may undergo class switch recombination, resulting in
a switch to a different constant region and consequently, a differ-
ent effector function. These cells may also undergo somatic hyper-
mutation, leading to an increase in antigen afﬁnity. Some of the
activated cells become memory B cells, whereas others differenti-
ate into plasma cells that secrete high levels of antibodies. B-1 B
cells and marginal zone B cells, which are located in the marginal
zone of the spleen, are thought to contribute to natural antibodies.
In addition, they rapidly respond to T-cell independent antigens,
such as polyclonal B-cell activators that stimulate Toll-like recep-
tors and the large polyscaccharide structures on bacteria, such as
Haemophilus inﬂuenzae and Streptococcus pneumoniae. Moreover,
we have recently described yet another mature B-cell subset, the
CD21CD23 population, which is present in peripheral lymphoid
organs (spleen and lymph nodes) [27]. Currently, little is known
about this B-cell population, except that it can express autoreactive
BCRs under certain conditions.
5. Immunodeﬁciency and systemic autoimmunity
Since the humoral arm of the immune system is essential in the
defence against pathogens, antibody deﬁciencies result in in-
creased susceptibility to infections with bacteria, such as S. pneu-
moniae and H. inﬂuenzae, which cause bronchitis and pneumonia,
often leading to chronic lung disease in these patients. Mutations
or other alterations that ultimately affect the signals intrinsic to
B-lineage cells or other cell lineages, and thereby the microenvi-
ronment, can lead to antibody deﬁciencies [28]. For instance,
approximately 15% of patients with defects in early B-cell develop-
ment exhibit defective pre-BCR or BCR components, and the major-
ity of the remaining patients have mutations in Bruton’s tyrosine
kinase (associated with X-linked agammaglobulinaemia), a signal-
ling molecule that is located downstream of the pre-BCR. However,
the humoral arm of the immune system is not always protective, as
it is also a factor in systemic autoimmune diseases [29]. These are
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that involve a genetic component as well as other factors, and
are characterised by a break down of tolerance. Although the exact
mechanisms underlying the onset of disease are unknown, the
pathogenesis of SLE involves pathogenic autoantibodies that form
immune complexes, which in turn activate the complement sys-
tem to cause tissue destruction.
6. The pre-BCR checkpoint
It is clear that as they develop into mature B cells, a system of
quality control is essential, to ensure that the cells have reached
the competence required for that particular stage before they are
allowed to continue on the pathway to becoming mature B cells.
One of the major checkpoints, at which selection takes place, relies
on BCR expression. As the BCR is a membrane-anchored antibody,
this checkpoint is to some extent obvious. However, a less-obvious
major checkpoint is that based on expression of the pre-BCR [9]. In
this case, the cell is monitored to determine whether it has suc-
cessfully completed VDJH recombination and expresses a func-
tional lH chain (Fig. 4). According to current models, in order for
the cells to pass this checkpoint, the pre-BCR has to be expressed
on the cell surface and transduce signals so that there is: (1) cellu-
lar transition from the pre-BI to the pre-BII stage; (2) lH chain alle-
lic exclusion and down-regulation of the recombination
machinery, including recombination-activating genes (RAG); (3)
positive selection; (4) negative selection; (5) proliferation; and
(6) termination of VpreB and k5 (SL chain) transcription. Below,Igα Igβ
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Fig. 4. Pre-BCR-mediated signals. Schematic overview of the pre-BCR and the processes i
and the SL chain (SLC), which consists of the two invariant polypeptides k5 (blue) and Vwe discuss whether the pre-BCR alone or the lH chain alone is suf-
ﬁcient to transmit these signals. We will then turn our attention to
the requirement for cell surface expression, and the role of extra-
cellular pre-BCR ligand(s) (as opposed to intracellular signalling),
and this is followed by a short summary.
7. Cellular transition from the pre-BI to the pre-BII stage
It is clear that a signal is required to induce cellular transition
from the pre-BI stage to the pre-BII stage. This is based on the
observation that targeting of the Igab signalling molecules results
in a complete block at the pre-BI stage during B-cell development
[30]. The absence of the transmembrane region of the lH chain
(lMT mice) also results in a complete block at the pre-BI stage
[31]. Although this demonstrates the importance of this region,
this does not directly address the issue of whether cell surface
expression is required, as the transmembrane region is also in-
volved in intracellular assembly with the signalling molecules
Igab. In terms of a requirement for the pre-BCR, targeting of the
SL chain components, either alone (k5 T, VpreB-deﬁcient) or all to-
gether (SL/), results in a block at the expected stage and enrich-
ment of pre-BI cells [32–34]. However, this block is incomplete,
and although the numbers of cells at the pre-BII and subsequent
cellular stages are decreased, B cells do develop. The transition
from the pre-BI to the pre-BII cell stage has been attributed to
the ability of transitional pre-BI cells, despite of the fact that they
lack the SL chain, to express signalling-competent lH chains on
their surfaces [35,36]. Taken together, these ﬁndings suggest thatVpreB
VH
λ5
CH
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ection
3
Negative selection
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n which it participates. The pre-BCR consists of a recombined Ig H chain (HC, green)
preB (red).
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is required to induce cellular transition from the pre-BI to the pre-
BII stage.
8. Allelic exclusion
The mechanism of Ig H chain allelic exclusion ensures that only
one of the two alleles encodes a H chain protein [37]. With regard
to the Ig L chain, only one of the two chains (j or k) is expressed
(isotype exclusion) from one allele (allelic exclusion). The critical
importance of allelic and isotype exclusion becomes apparent
when one considers the consequences of allelic and isotype inclu-
sion. If both lH chain, both jL chain, and both kL chain alleles are
expressed, each with a different V(D)J recombination and therefore
recognising a different antigen, the number of possible combina-
tions is 30. As the BCR is a dimer of a heterodimer, most of the BCRs
would be bi-speciﬁc. Presumably, this would lead to difﬁculties at
the activation stage, which requires receptor cross-linking upon
antigen binding. Therefore, allelic and isotype exclusion ensures
efﬁcient B-cell activation and humoral immune responses. It also
avoids the additional risk of co-expressed receptors being poten-
tially autoreactive.
At the DNA level, one H chain allele at a time undergoes VH to
DJH recombination. If the ﬁrst allele is successfully recombined
and results in a lH chain, the second allele remains DJH-recom-
bined. In contrast, if recombination is unsuccessful, the second al-
lele undergoes VH to DJH recombination. If neither of these
recombination events occurs, the cell dies. The existence of VDJH/
DJH-recombined cells suggests that a lH chain-mediated feedback
mechanism prevents further recombination of the second, DJH-
recombined allele, as well as halting the recombination machinery
[17]. The notion of a feedback inhibition mechanism is supported
by the observed ratio for VDJH/DJH-recombined to VDJH/VDJH-
recombined alleles in transitional pre-BI, pre-BII, and splenic B
cells of approximately 1:1, which is close to the value expected
from theory [38–40]. Additional mechanisms must be active that,
for instance, initiate recombination of one allele at a time and pro-
tect the H chain locus from further recombination when the RAG
genes are reactivated in order to recombine the L chain loci. These
issues will not be discussed here.
The transmembrane region of the lH chain is required for H
chain allelic exclusion, as evidenced by the analysis of B cells from
heterozygous lMT mice (homozygous mutants cannot be used be-
cause they lack B cells), which exhibit allelic inclusion [38,41].
However, the question as to whether cell surface expression is re-
quired has not yet been answered, as the argument based on the
lMT mice is the same as that discussed above. Regarding the
requirement for a functional pre-BCR, analysis of cells from k5 T
mice has suggested that H chain allelic exclusion is intact in these
mice, although others have reported differently [39,40]. The reason
for the discrepancy is unclear.
During B-cell development, the recombination of ﬁrst the H
chain and then the L chain loci correlates with RAG gene expression
[42], in that the kinetics of their expression shows two peaks: the
ﬁrst with up-regulation in pre-BI cells and down-regulation in
large pre-BII cells; and the second with high levels in small pre-
BII cells and low levels in immature B cells. Thus, the ﬁrst wave
correlates with a role for the pre-BCR and, indeed, it has been
shown that RAG expression is down-regulated in pre-BCR-express-
ing cells. However, our observation that H chain expression in the
absence of a pre-BCR (k5T), in an Iga signalling-dependent manner,
is sufﬁcient to terminate RAG expression (at both the protein and
transcriptional levels), suggests that this process is pre-BCR-inde-
pendent [35]. The requirement for RAG in VDJH recombination
and the above data suggest that H chain allelic exclusion is pre-
BCR-independent.9. Pre-BCR-driven positive selection
Based on their sequence homologies, the VH gene segments can
be divided into families, with the >100 mouse VH gene segments
being categorised into 16 families. In mature, splenic B cells of
adult mice, VH gene usage closely reﬂects the estimated size of
each VH gene family, i.e. VH7183 and VHJ558 represent approxi-
mately 10% and 60%, respectively, of the total VH gene usage. How-
ever, VH7183 usage is over-represented and that of VHJ558 is under-
represented in bone marrow transitional pre-BI cells (and early in
ontogeny) [43]. This observation may be explained by the locations
of the VH families in the genome, such that VH gene segments that
have a D-proximal location are more frequently used for VDJH
recombination than those that are located closer to the 50-end
(the VH gene segments span 2.5 Mb). Nonetheless, there is a shift
in VH gene usage and the actual shift takes place at the pre-BI to
pre-BII cell transition [44]. The fact that this coincides with pre-
BCR expression implies that VH selection is driven by the SL chain.
A striking example of this selection is one of the most D-proxi-
mal VH genes, VH81X(VH7183 family), the usage of which is high in
bone marrow pre-BI cells but very low in pre-BII and splenic B cells
[43]. Based on studies in pre-B cell lines, VH81X-encoded lH chains
are unable to assemble with the SL chain and reach the cell surface
[9]. Because other VH family members are also unable to form a
pre-BCR, this suggests a model of VH repertoire selection in which
only cells that express lH chains and that pair with the SL chain
are positively selected into the pre-BII stage. It has been estimated
that as many as half of all lH chains are unable to pair with SL
chain, making this a major selection point. However, the VH seg-
ment (encoding CDR1 and CDR2) cannot be the only determinant,
as there are peripheral B cells that express VH81X-encoded lH
chains, and with only one such gene segment they only differ with
respect to their CDR3, suggesting the involvement of this region as
well, at least when it comes to VH81X [43].
A requirement for the pre-BCR in positive selection is sup-
ported by the observation that the VH repertoire in splenic B cells
of k5 T mice is similar to that of control wild-type mice [44]. This
has led to a model whereby in the absence of a functional SL
chain, VH repertoire selection is temporally delayed until the B
cell stage in which L chains perform positive selection. In this sce-
nario, the role of the SL chain is to ensure that only cells that ex-
press lH chains and that are subsequently able to pair with L
chains are positively selected. In support of this model, lH chains
that are unable to pair with both SL and L chains have been de-
scribed [43]. However, there are also examples of lH chains
assembling with L chains despite being unable to pair with the
SL chain [45], suggesting that this is not an absolute requirement.
Ultimately selection at this stage affects the antibody repertoire
and, consequently, the ability of the individual to mount a protec-
tive humoral immune response.10. Pre-BCR-mediated negative selection
The V(D)J recombination process of the H and L chain loci is ran-
dom and may result in BCRs recognising self (auto)-antigens. Sev-
eral mechanisms of negative selection, such as receptor editing
(secondary VL to JL recombinations), clonal deletion (apoptosis),
and anergy (non-responsiveness to antigen), are in place to ensure
that those B cells that express an autoreactive BCR are rendered
‘harmless’ [46]. Selection takes place at several stages, for instance,
it has been found that the proportion of B cells that express auto-
reactive BCRs, including those with anti-nuclear speciﬁcities, de-
creases as the cells mature [47]. If autoreactive B cells escape
negative selection, there is the risk that, in the presence of the
appropriate antigen, they will differentiate into autoantibody-
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present, this may result in the secretion of pathological autoanti-
bodies and the development of systemic autoimmune disease,
e.g., SLE [29].
Recently, we showed that the pre-BCR is involved in censoring
the development of autoreactive B cells [27]. Thus, in mice that lack
a functional pre-BCR (SL/), there is an increase in the titres of
autoantibodies directed against nuclear antigens (anti-nuclear anti-
bodies). This phenotype may be linked to a subset of mature B cells
(CD2123) that is enriched in the SL/ mice. The lH chains ex-
pressed by these cells are unusual in that the HC-CDR3s contain a
high proportion of basic amino acids (aa), especially arginines. At
the molecular level, it is known that HC-CDR3s that contain basic
aa may result in antibodies with speciﬁcity for DNA [48]. The pres-
ence of autoreactive B cells in SL/ mice could be the result of
either escape from pre-BCR-mediated negative selection or simply
because of the overall reduction in peripheral B cells in these mice.
However, additional experiments have suggested the existence of a
pre-BCR checkpoint. Pre-BI cells from both control mice and SLC/
LC/ (lacking both the SL and L chains; to exclude involvement
of L chains) mice expressed HC-CDR3s with multiple basic aa. How-
ever, in the pre-BII cells of the control mice, these types of HC-
CDR3s were reduced, whereas in the SLC/LC/ mice they re-
mained high. Moreover, short-term in vitro culturing of pre-BI cells
under conditions that prevent further development resulted in the
loss of such HC-CDR3s in the presence, but not the absence, of the SL
chain. These results suggest that the pre-BCR negatively selects
cells that express HC-CDR3s with multiple basic aa.
In accordance with our data are the ﬁndings for mice that
underwent manipulation of the DH segment so that arginine, histi-
dine, and asparagine residues were used in place of tyrosine and
glycine. In this case, a HC-CDR3 that contained multiple arginines
resulted in the relative accumulation of fraction B cells (pre-BI
cells) and a decrease in the cell numbers in the subsequent stages
(Philadelphia nomenclature), thus supporting the presence of a
pre-BCR checkpoint [49]. In addition, the presence of serum auto-
antibodies to DNA was noted.
Furthermore, in a patient that expresses a mutated k5, a rela-
tively high proportion of the pre-B cells (pre-BII cells) were found
to express lH chains with multiple basic aa in the HC-CDR3s,
termed ‘aberrant’ lH chains [50]. However, this k5 mutation leads
to a complete block in B-cell development and agammaglobulina-
emia, and it is not possible to test for the potential occurrence of
autoantibodies [3]. We conclude that cells that express HC-CDR3s
with multiple basic aa undergo negative selection in a pre-BCR-
dependent manner, thereby censoring the development of poten-
tially autoreactive B cells.
The exact mechanism of pre-BCR-mediated negative selection
of mouse pre-B cells that express HC-CDR3s with multiple basic
aa is currently unclear [27]. It is possible that they are simply un-
able to pair with the SL chain and assemble into a pre-BCR due to
conformational restraints, although, at least in humans, ‘aberrant’
lH chains are able to pair [50]. Another possibility is that the ‘aber-
rant’ lH chains induce apoptosis, for which there is support from
experiments conducted using a T-cell line [50]. Further studies
are needed to address these issues.11. Proliferation and down-regulation of SL chain and the pre-
BCR
As cells transit from the pre-BI to pre-BII stage, the pre-BCR in-
duces a signal for proliferative expansion. Despite the fact that this
represents clonal expansion, it ultimately results in a more diverse
antibody repertoire, as later in development, each cell will recom-
bine and express a unique L chain. In mice that lack SL chain orcomponents thereof, pre-BII cell expansion is greatly reduced,
which suggests that the pre-BCR is required for this process [51].
Using an experimental system that relies on the ability to induce
lH chain/pre-BCR expression, pre-BCR dependency was shown
more directly [52].
Aswell as inducingproliferation, thepre-BCR is believed to signal
its own down-regulation by silencing transcription of the genes that
encode the SL chain, based on the VpreB and k5 mRNA levels [42].
However, our analyses of k5 primary transcription revealed an unu-
sual pattern of regulation; bi-allelic transcription in pre-BI cells and
in pre-BCR-expressing transitional pre-BI cells, but mono-allelic
transcription in large pre-BII cells followed by silencing also of the
second allele in small pre-BII cells [53]. Based on these observation,
this suggest that transcriptional silencing does not correlate with
pre-BCR expression per se but ratherwith pre-BCR-induced prolifer-
ation. Even so, initiation of transcriptional silencing has been found
to be pre-BCR-dependent, although it requires additional signals,
which are presumably active in pre-BII but not in transitional pre-
BI cells. Transcriptional silencing clearly affects SL chain protein lev-
els, althoughthis isnot reﬂected in thepre-BCR levels, beingvery low
in freshly isolated cells. Therefore, an alternative explanation is that
mono-allelic silencing of the genes encoding SL chain is away to pre-
pare the cells for leaving the cell cycle but not for directly down-reg-
ulating the receptor itself.12. Cell surface signalling versus intracellular signalling
The VpreB and k5 polypeptides show homology to the Ig V and
Ig C regions, respectively. In addition, each polypeptide contains a
unique region (UR). In the mouse, the VpreB-UR contains 21 aa,
and the k5-UR contains 50 aa, including seven arginines [43]. The
latter is involved in pre-BCR-mediated signalling and localisation.
In a pre-B cell line, established from k5 T mice, mutations in the
k5-UR abolished signalling, as well as pre-BCR internalisation
[54]. In an in vivo set-up, the expression of a transgenic k5 poly-
peptide that lacked the k5-UR resulted in reduced pre-BII cell
expansion [55], supporting the importance of surface pre-BCR
expression and a signal that mediates pre-BII-cell proliferation.
On the cell surface, the pre-BCR may mediate a signal that is
cell-autonomous, either by direct or indirect cross-linking. Alterna-
tively, or in addition, pre-BCR-mediated signalling may rely on a li-
gand; in this regard, several candidate ligands have been
characterised. In mice, one of these is present on stromal cells,
stromal cell-associated heparan sulfate, a ligand that interacts with
the pre-BCR, which requires the k5-UR [43]. In both mice and hu-
mans, galectin-1, a soluble ligand secreted by stromal cells, has
been identiﬁed [56]. The pre-BCR recognises this ligand in the con-
text of integrins that are present on both the pre-B and stromal
cells. Interaction with this ligand, which also requires the k5-UR,
results in the formation of a synapse and initiation of pre-BCR sig-
nalling. In an in vivo experimental system with mice that lack the
galectin-1 ligand, B-cell development appeared normal [57]. How-
ever, after in vivo hydroxyurea treatment, which causes the deple-
tion of proliferating cells, the pre-BII cell numbers were not
restored as quickly in galectin-1-deﬁcient mice as in control mice,
due to a more pronounced effect on proliferation during the recov-
ery phase. Thus, galectin-1, presumably through its activity as a
pre-BCR ligand, is important for optimal pre-BII-cell expansion.
Recently, it has been reported that the k5-UR can be replaced by
a HC-CDR3 that contains multiple arginines so as to induce prolif-
eration, perhaps due to interactions between the arginines in the
k5-UR/HC-CDR3 and negatively charged components of the sur-
faces of cells, e.g., stromal cells [58]. This observation may explain
the survival in the absence of the SL chain of cells that express lH
chains with multiple arginines. It is possible that the arginines in
2578 I.-L. Mårtensson et al. / FEBS Letters 584 (2010) 2572–2579these HC-CDR3s interact with negatively charged species on stro-
mal cells. With seven arginines in the k5-UR and only two or three
arginines in the HC-CDR3s, the latter may result in a survival signal
rather than a proliferation signal. Nevertheless, these observations
support the importance of pre-BCR surface expression for the
transmision of a proliferation signal, and this requires the k5-UR,
interacting either in a cell-autonomous fashion or with stromal
cells, in the presence or absence of ligand.
In light of this, it may seem contradictory that cell surface
expression of the pre-BCR might not be necessary for its signalling
capacity. It has been shown that localisation of the pre-BCR com-
plex to the trans-Golgi network, but not to the endoplasmic retic-
ulum, is sufﬁcient for proliferation and the up-regulation of marker
expression [59]. This raises the possibility that some of the pre-
BCR-mediated signals are transduced intracellularly rather than
at the cell surface.
13. Summary
We have discussed the role of the pre-BCR at the ﬁrst major
checkpoint during early B-cell development. Based on current
knowledge, we propose that some of these signals do not require
the pre-BCR. The pre-BCR-independent signals include H chain alle-
lic exclusion anddown-regulation of the RAG genes. This process ap-
pears to take place as soon as the cells have synthesised a lH chain,
which is in line with the notion of a feedback signal, and is already
apparent in transitional pre-BI cells. The time frame in which this
mechanismoperates is unknown, as is the compartment fromwhich
the signal is delivered. It is possible that the lH chain-mediated
feedback signal that results in H chain allelic exclusion does not re-
quire surface expression, sincelHchains alone (in the absenceof k5)
can induce signalling, albeit at a low level, from the trans-Golgi net-
work [59]. Furthermore, it is possible that the signal for H chain alle-
lic exclusion also induces cellular transition from the pre-BI to the
pre-BII stage, since a functional H chain is sufﬁcient for this process.
This suggests that pre-BCR-mediated positive selection does not
determine the pre-BI to pre-BII transition per se but rather the clonal
expansion that follows. In this case, the strength of the pairing be-
tween the lH and SL chains may determine the amplitude of the
transmitted signal, and thereby, the extent of proliferation [60].
Optimal expansion would depend on interaction with a ligand
and/or with stromal cells. Whether pre-BCR-mediated negative
selectionof cells that expresspotentially autoreactivelHchainsalso
requires interaction with a ligand remains to be elucidated.
We conclude that the pre-BCR plays an essential role in B-cell
development, even though it may not be directly involved in H
chain allelic exclusion. The pre-BCR is essential for both positive
and negative selection, as well as for proliferative expansion, and
therefore inﬂuences humoral immune responses. Mutations or
other alterations that impinge on its signalling capacity may result
in antibody deﬁciency and underpin the development of multifac-
torial diseases, such as leukemia, and, perhaps, even systemic
autoimmunity.Acknowledgements
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